Search

everythinglearnresearchcommunity

for

Search:↓

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.

The EQ-5D-5L tool may not accurately measure the impact of alopecia areata on patients' lives.

A change in SALT scores of 42 or 43 indicates meaningful improvement in alopecia areata treatment.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Telemedicine is effective for diagnosing hair loss, especially in people with darker skin, during the pandemic.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Kids with alopecia areata had lower vitamin D levels than healthy kids.

Tofacitinib shows promise for treating alopecia areata with significant hair regrowth and mild side effects.

Individualized Homeopathic Medicine shows promise for treating alopecia with lasting hair regrowth.

Intralesional methotrexate and triamcinolone acetonide are more effective than Vitamin D3 for treating alopecia areata.

Bempikibart may help regrow hair in people with alopecia areata.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

The study helps doctors use patient images to understand and apply SALT scores for treating severe alopecia areata.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Low vitamin D levels might indicate more severe hair loss in alopecia areata patients.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

Tofacitinib is an effective and safe treatment for alopecia areata.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

People with alopecia areata often have lower vitamin D levels, which may be linked to the condition's severity.

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.

AI can accurately measure hair loss severity in alopecia areata.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Combining DPCP with PRP doesn't improve hair regrowth in alopecia areata.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Mesalazine showed limited effectiveness in treating children with severe alopecia areata.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.